SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-039263
Filing Date
2023-03-30
Accepted
2023-03-30 17:11:48
Documents
15
Period of Report
2023-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310752d3_8k.htm   iXBRL 8-K 39896
2 EXHIBIT 1.1 tm2310752d3_ex1-1.htm EX-1.1 297372
3 EXHIBIT 3.1 tm2310752d3_ex3-1.htm EX-3.1 64040
4 EXHIBIT 5.1 tm2310752d3_ex5-1.htm EX-5.1 52231
  Complete submission text file 0001104659-23-039263.txt   733562

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA avdl-20230329.xsd EX-101.SCH 3085
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20230329_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20230329_pre.xml EX-101.PRE 22591
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2310752d3_8k_htm.xml XML 3590
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 23781693
SIC: 2834 Pharmaceutical Preparations